BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 203,615 Value ($000) $261 Avg Close — Range —
Q1 2024
Shares 190,970 Value ($000) $539 Avg Close — Range —
Q4 2023
Shares 187,510 Value ($000) $553 Avg Close — Range —
Q3 2023
Shares 136,803 Value ($000) $346 Avg Close — Range —
Q2 2023
Shares 148,174 Value ($000) $987 Avg Close — Range —
Q1 2023
Shares 143,893 Value ($000) $2,685 Avg Close — Range —
Q4 2022
Shares 143,282 Value ($000) $3,078 Avg Close — Range —
Q3 2022
Shares 140,493 Value ($000) $1,661 Avg Close — Range —
Q2 2022
Shares 125,139 Value ($000) $1,652 Avg Close — Range —
Q1 2022
Shares 135,310 Value ($000) $2,830 Avg Close — Range —
Q4 2021
Shares 131,708 Value ($000) $2,678 Avg Close — Range —
Q3 2021
Shares 129,964 Value ($000) $3,945 Avg Close — Range —
Q2 2021
Shares 102,744 Value ($000) $2,986 Avg Close — Range —
Q1 2021
Shares 96,021 Value ($000) $4,145 Avg Close — Range —
Q4 2020
Shares 93,618 Value ($000) $4,326 Avg Close — Range —
Q3 2020
Shares 90,875 Value ($000) $3,941 Avg Close — Range —
Q2 2020
Shares 26,422 Value ($000) $1,401 Avg Close — Range —
Q1 2020
Shares 15,232 Value ($000) $341 Avg Close — Range —
Q4 2019
Shares 15,092 Value ($000) $221 Avg Close — Range —
Q3 2019
Shares 12,536 Value ($000) $89 Avg Close — Range —
Q2 2019
Shares 12,536 Value ($000) $138 Avg Close — Range —